Newsroom

Stay up to date with what’s happening at ONO PHARMA USA.

Doctor meeting with a patient
Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area
Press Release
December 6, 2024
ONO Pharmaceutical Co., Ltd. Announced 2024 Q2 Financial Results
Press Release
October 31, 2024
ONO PHARMA USA Announces Support for Conquer Cancer®, the ASCO Foundation
Press Release
June 24, 2024
ONO PHARMA USA Announces 2024 Golden Ticket Competition Now Accepting Applications from Innovative Startups
Press Release
May 2, 2024
ONO PHARMA Announces Enrollment Is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL
Press Release
March 21, 2024
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Press Release
March 11, 2024
Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins
Press Release
February 13, 2024
ONO Selected as Highest Rating A-List Company by CDP in Two Categories of “Climate Change” and “Water Security” in CDP 2023
Press Release
February 7, 2024
Support for Disasters Caused by the 2024 Noto Peninsula Earthquake
Press Release
January 9, 2024
Ono Enters into Collaboration Agreement with EVQLV to Generate Novel Antibodies against Multiple Targets Utilizing EVQLV’s AI-powered Antibody Design Engine for Development of Innovative Antibody Drugs
Press Release
December 19, 2023